Page last updated: 2024-08-21

nicotinamide mononucleotide and Age-Related Osteoporosis

nicotinamide mononucleotide has been researched along with Age-Related Osteoporosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bian, J; Dunstan, CR; Jiang, L; Jiang, X; Lesani, P; Li, N; Li, Y; Lu, Z; Luo, D; Wang, G; Ye, Y; Zhang, W; Zreiqat, H1
Huang, RX; Tao, J1

Other Studies

2 other study(ies) available for nicotinamide mononucleotide and Age-Related Osteoporosis

ArticleYear
Nicotinamide Mononucleotide Alleviates Osteoblast Senescence Induction and Promotes Bone Healing in Osteoporotic Mice.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2023, 02-24, Volume: 78, Issue:2

    Topics: Animals; Humans; Mice; NAD; Nicotinamide Mononucleotide; Osteoblasts; Osteogenesis; Osteoporosis; Tumor Necrosis Factor-alpha

2023
Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway.
    Molecular medicine reports, 2020, Volume: 22, Issue:1

    Topics: Animals; Cell Line; Dexamethasone; Glucocorticoids; Humans; Mesenchymal Stem Cells; Mice, Inbred C57BL; Nicotinamide Mononucleotide; Osteogenesis; Osteoporosis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protective Agents; Signal Transduction; Sirtuin 1

2020